Vilin Bio Med (NSE:VILINBIO) Debt-to-Equity : 0.24 (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med Debt-to-Equity?

Vilin Bio Med's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₹52.72 Mil. Vilin Bio Med's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₹2.53 Mil. Vilin Bio Med's Total Stockholders Equity for the quarter that ended in Sep. 2023 was ₹234.47 Mil. Vilin Bio Med's debt to equity for the quarter that ended in Sep. 2023 was 0.24.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Vilin Bio Med's Debt-to-Equity or its related term are showing as below:

NSE:VILINBIO' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.24 Med: 0.67 Max: 0.75
Current: 0.24

During the past 3 years, the highest Debt-to-Equity Ratio of Vilin Bio Med was 0.75. The lowest was 0.24. And the median was 0.67.

NSE:VILINBIO's Debt-to-Equity is ranked better than
56.25% of 848 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs NSE:VILINBIO: 0.24

Vilin Bio Med Debt-to-Equity Historical Data

The historical data trend for Vilin Bio Med's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med Debt-to-Equity Chart

Vilin Bio Med Annual Data

Trend

Mar20

Mar21

Mar22

Debt-to-Equity

0.63

0.75

0.72

Vilin Bio Med Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Sep23
Debt-to-Equity	0.63	0.75	0.72	N/A	0.24

Competitive Comparison of Vilin Bio Med's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Vilin Bio Med's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vilin Bio Med's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vilin Bio Med's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Vilin Bio Med's Debt-to-Equity falls into.

Vilin Bio Med Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Vilin Bio Med's Debt to Equity Ratio for the fiscal year that ended in Mar. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(45.656	+	7.34)	/	73.962
	=	0.72

Vilin Bio Med's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(52.717	+	2.525)	/	234.467
	=	0.24

Vilin Bio Med (NSE:VILINBIO) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Vilin Bio Med Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilin Bio Med (NSE:VILINBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009

Website

http://www.vilinbiomed.co.in

Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines